mesalamine and aspirin

mesalamine has been researched along with aspirin in 42 studies

Research

Studies (42)

TimeframeStudies, this research(%)All Research%
pre-19902 (4.76)18.7374
1990's6 (14.29)18.2507
2000's14 (33.33)29.6817
2010's17 (40.48)24.3611
2020's3 (7.14)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Arya, P; Biswal, S; DePass, AL; Ghosh, B; Kumar, S; Malhotra, S; Olsen, CE; Parmar, VS; Prasad, AK; Singh, BK; Thimmulappa, R; Van der Eycken, E1
Hong, S; Jung, Y; Kang, S; Kim, J; Kim, YM; Yum, S1
Brun, P; Carta, D; Castagliuolo, I; Dean, A; Di Marco, V; Ferlin, MG; Surajit, P1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ban, HS; Ishihara, K; Nabeyama, W; Nakamura, H; Wada, H1
Chung, HY; Hong, J; Ju, Z; Jung, JH; Kim, S; La Kim, E; Moon, HR; Su, M1
Briggs, D; Calder, I; Tange, J; Woods, R1
Schölmerich, J1
Verspaget, HW1
Dierickx, PJ; Janssen, L; Noble, E1
Dalsgaard, CJ; Haegerstrand, A; Martinsson, T1
Adler, G; Liptay, S; Schmid, RM; Wahl, C1
Florholmen, J; Støa-Birketvedt, G1
Allgayer, H; Hombach, A; Kruis, W; Pohl, C; Tillmann, T1
Alarcón, A; Martínez, JG; Morey, A; Saus, C1
BROUILHET, H; BUU-HOUI, NP; DELBARRE, F; JACQUIGNON, P; KAHAN, A; MARTY, M1
Berkels, R; Schömig, E; Taubert, D1
Gasche, C1
Bischoff, SC; Fleig, W; Reissmann, A1
Konstantinou, G; Liatsos, C; Paraskevopoulos, I1
Boland, CR; Gasche, C; Goel, A; Natarajan, L1
Backhaus, B; Baenkler, HW; Buchwald, F; Hahn, EG; Kimpel, S; Koch, H; Konturek, PC; Mach, K; Naegel, A; Raithel, M; Schultis, HW1
Farinati, F; Herszényi, L; Miheller, P; Tulassay, Z1
Bazuro, GE; Capurso, L; Gasparini, G; Torino, F1
Lal, R; Pilgrim, S; Tsiamis, A; Velchuru, V; Waters, G1
Abreu, MT; Mayer, L; Murphy, SJ1
Blagbrough, IS; Elmasry, MS; Kheir, AA; Rogers, PJ; Rowan, MG; Saleh, HM1
Barreiro-de-Acosta, M; Campos-Franco, J; Losada-Ares, L; Pérez-Pampín, E1
Bhuket, T; Mosadeghi, S; Stollman, N1
Dilwali, S; Fujita, T; Kao, SY; Landegger, LD; Stankovic, KM1
Bell, MC; Chervinskiy, S; Heath, JL; Heath, RD; Johnson, L; Kennedy, JL; Tamboli, C; Wilson, AS1
Boros, M; Érces, D; Ghyczy, M; Hartmann, P; Jász, DK; Lajkó, N; Molnár, R; Szűcs, S; Tóth, G; Ugocsai, M; Varga, G1
Benyerbah, N; Ispas-Szabo, P; Mateescu, MA; Sakeer, K1
Gupta, N; Hanauer, SB1
Chan, FKL; Chan, KH; Chow, WH; Hui, AJ; Lam, BCY; Leung, CM; Leung, WK; Li, M; Lo, FH; Mak, JWY; Ng, KM; Ng, SC; Shan, EHS; So, J; Sze, SF; Tang, W; Tsang, SWC; Yip, TCF1
Doyama, H; Ezoe, Y; Hori, S; Horimatsu, T; Ikematsu, H; Ishikawa, H; Kashida, H; Mure, K; Mutoh, M; Nakajima, T; Ohda, Y; Otani, T; Sakai, T; Sato, Y; Suzuki, S; Tajika, M; Takayama, T; Takeuchi, Y; Tanaka, S; Tashiro, J; Wakabayashi, K1
Lynch, PM1

Reviews

8 review(s) available for mesalamine and aspirin

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Effects of mesalazine on lamina propria white cell functions.
    Advances in experimental medicine and biology, 1995, Volume: 371A

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Aspirin; Clinical Trials as Topic; Connective Tissue Cells; Cytotoxicity, Immunologic; Double-Blind Method; Inflammation; Intestinal Mucosa; Killer Cells, Natural; Leukocytes; Macrophages; Mast Cells; Mesalamine

1995
[Aspirin--a suitable drug for cancer prevention?].
    Deutsche medizinische Wochenschrift (1946), 2004, Feb-27, Volume: 129, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cost-Benefit Analysis; Cyclooxygenase Inhibitors; Epidemiologic Studies; Humans; Mesalamine; Neoplasms; Primary Prevention; Randomized Controlled Trials as Topic; Risk Assessment

2004
Review article: the chemoprevention of colorectal carcinoma.
    Alimentary pharmacology & therapeutics, 2004, Volume: 20 Suppl 4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Chemoprevention; Chromosomal Instability; Colitis; Colorectal Neoplasms; Humans; Mesalamine; Microsatellite Repeats; Precancerous Conditions

2004
Chemoprevention of colorectal cancer: feasibility in everyday practice?
    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2008, Volume: 17, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Chemoprevention; Clinical Trials as Topic; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Dietary Supplements; Family Practice; Feasibility Studies; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mesalamine; Ursodeoxycholic Acid

2008
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all?
    Minerva gastroenterologica e dietologica, 2008, Volume: 54, Issue:4

    Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colorectal Neoplasms; ErbB Receptors; Esophageal Neoplasms; Gastrointestinal Neoplasms; Humans; Mesalamine; Probiotics; Stomach Neoplasms

2008
Diverticular disease: evolving concepts in classification, presentation, and management.
    Current opinion in gastroenterology, 2015, Volume: 31, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colonoscopy; Dietary Fiber; Diverticulosis, Colonic; Humans; Mesalamine

2015

Trials

3 trial(s) available for mesalamine and aspirin

ArticleYear
The systemic load and efficient delivery of active 5-aminosalicylic acid in patients with ulcerative colitis on treatment with olsalazine or mesalazine.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:3

    Topics: Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chromatography, High Pressure Liquid; Colitis, Ulcerative; Colon; Cross-Over Studies; Female; Humans; Male; Mesalamine; Middle Aged

1999
Significance of salicylate intolerance in diseases of the lower gastrointestinal tract.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2005, Volume: 56 Suppl 5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis, Ulcerative; Crohn Disease; Diet; Drug Hypersensitivity; Food Hypersensitivity; Gastrointestinal Diseases; Humans; Irritable Bowel Syndrome; Lower Gastrointestinal Tract; Malabsorption Syndromes; Mesalamine; Salicylates

2005
Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
    The lancet. Gastroenterology & hepatology, 2021, Volume: 6, Issue:6

    Topics: Adenomatous Polyposis Coli; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Chemoprevention; Colectomy; Colonoscopy; Colorectal Neoplasms; Double-Blind Method; Drug Therapy, Combination; Humans; Incidence; Japan; Mesalamine; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Placebo Effect; Quality of Life

2021

Other Studies

31 other study(ies) available for mesalamine and aspirin

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Novel natural product-based cinnamates and their thio and thiono analogs as potent inhibitors of cell adhesion molecules on human endothelial cells.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:11

    Topics: Biological Products; Cell Adhesion; Cell Adhesion Molecules; Cinnamates; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Neutrophils; Structure-Activity Relationship; Sulfur; Tumor Necrosis Factor-alpha

2011
Structure-activity relationship of salicylic acid derivatives on inhibition of TNF-α dependent NFκB activity: Implication on anti-inflammatory effect of N-(5-chlorosalicyloyl)phenethylamine against experimental colitis.
    European journal of medicinal chemistry, 2012, Volume: 48

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Chemokine CXCL2; Colitis; HCT116 Cells; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Molecular Structure; NF-kappa B; Rats; Salicylates; Spectrophotometry, Infrared; Structure-Activity Relationship; Tumor Necrosis Factor-alpha

2012
Peroxisome proliferator-activated receptor-γ mediates the anti-inflammatory effect of 3-hydroxy-4-pyridinecarboxylic acid derivatives: synthesis and biological evaluation.
    European journal of medicinal chemistry, 2013, Volume: 62

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Dose-Response Relationship, Drug; Humans; Isonicotinic Acids; Lipopolysaccharides; Macrophages; Molecular Structure; PPAR gamma; RNA, Messenger; Structure-Activity Relationship; Transcription, Genetic

2013
Discovery of (2-aminophenyl)methanol as a new molecular chaperone that rescues the localization of P123S mutant pendrin stably expressed in HEK293 cells.
    Bioorganic & medicinal chemistry, 2017, 05-01, Volume: 25, Issue:9

    Topics: Amino Acid Substitution; Benzyl Alcohols; Cell Membrane; Goiter, Nodular; Hearing Loss, Sensorineural; HEK293 Cells; Humans; Membrane Transport Proteins; Microscopy, Fluorescence; Salicylates; Sulfate Transporters

2017
Design of balanced COX inhibitors based on anti-inflammatory and/or COX-2 inhibitory ascidian metabolites.
    European journal of medicinal chemistry, 2019, Oct-15, Volume: 180

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Mice; Models, Molecular; Molecular Structure; RAW 264.7 Cells; Sheep; Structure-Activity Relationship; Urochordata

2019
The influence of metabolic variation on analgesic nephrotoxicity. Experiments with the Gunn rat.
    Pathology, 1982, Volume: 14, Issue:4

    Topics: Acetaminophen; Aminophenols; Aminosalicylic Acids; Analgesics; Animals; Aspirin; Genetic Carrier Screening; Homozygote; Kidney; Kidney Diseases; Male; Mesalamine; Rats; Rats, Gunn; Rats, Mutant Strains

1982
[5-aminosalicylic acid and thrombocyte function].
    Deutsche medizinische Wochenschrift (1946), 1995, May-19, Volume: 120, Issue:20

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Mesalamine; Myocardial Infarction; Platelet Aggregation

1995
Comparative cytotoxicity of 5-aminosalicylic acid (mesalazine) and related compounds in different cell lines.
    Cell biology and toxicology, 1997, Volume: 13, Issue:6

    Topics: Aminosalicylic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Line; Dogs; Glutathione; Humans; Kidney Tubules; Mesalamine; Neutral Red; Rats; Salicylates; Salicylic Acid; Structure-Activity Relationship; Swine; Tumor Cells, Cultured

1997
Effects of ropivacaine on eicosanoid release from human granulocytes and endothelial cells in vitro.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1997, Volume: 46, Issue:10

    Topics: 6-Ketoprostaglandin F1 alpha; Amides; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cells, Cultured; Eicosanoids; Endothelium, Vascular; Granulocytes; Humans; Hydrocortisone; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lidocaine; Mesalamine; Ropivacaine; Thrombin; Zymosan

1997
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.
    The Journal of clinical investigation, 1998, Mar-01, Volume: 101, Issue:5

    Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Blotting, Western; Cells, Cultured; Colonic Diseases; Cystine; Epithelial Cells; Fluorescent Antibody Technique, Indirect; Humans; Immunosuppression Therapy; Lipopolysaccharides; Mesalamine; NF-kappa B; Phorbol Esters; Phosphorylation; Plasmids; Proline; Recombinant Proteins; Recombination, Genetic; Sulfapyridine; Sulfasalazine; Thiocarbamates; Transcription Factor AP-1; Transfection; Tumor Necrosis Factor-alpha

1998
[Aminosalicylates and aspirin for colonic cancer: from anti-inflammatory to antineoplastic drugs?].
    Zeitschrift fur Gastroenterologie, 2000, Volume: 38, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Aspirin; Colonic Neoplasms; DNA Damage; Humans; Mesalamine; Treatment Outcome

2000
[Crohn's disease and renal amyloidosis. Acute renal failure].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2002, Volume: 22, Issue:4

    Topics: Acetaminophen; Acute Kidney Injury; Adrenal Cortex Hormones; Adult; Amyloidosis; Analgesics, Non-Narcotic; Aspirin; Autoimmune Diseases; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Mesalamine; Metronidazole; Renal Dialysis; Substance-Related Disorders

2002
[NON-STEROID ANTI-INFLAMMATORY AGENTS. I. DERIVATIVES OF 4- AND 5-AMINOSALICYLIC ACIDS].
    Medicina experimentalis : International journal of experimental medicine, 1964, Volume: 11

    Topics: 4-Aminobenzoic Acid; Aminopyrine; Aminosalicylic Acid; Aminosalicylic Acids; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antipyretics; Aspirin; Chloroquine; Edema; Mesalamine; Mice; Pharmacology; Research

1964
[Ulcerative colitis. Acute episode].
    Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:9

    Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mesalamine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors

2004
Desensitization treatment of an aspirin- and mesalamine-sensitive patient with Crohn's disease.
    Inflammatory bowel diseases, 2005, Volume: 11, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Crohn Disease; Desensitization, Immunologic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Hypersensitivity; Female; Humans; Mesalamine

2005
Mesalazine improves replication fidelity in cultured colorectal cells.
    Cancer research, 2005, May-15, Volume: 65, Issue:10

    Topics: Aspirin; Base Pair Mismatch; Cell Survival; Colorectal Neoplasms; DNA Repair; DNA Replication; Flow Cytometry; Frameshift Mutation; HCT116 Cells; Humans; Mesalamine

2005
[Chronic inflammatory bowel diseases. Proven and innovative in the treatment].
    MMW Fortschritte der Medizin, 2006, Jun-15, Volume: 148, Issue:24

    Topics: Administration, Oral; Administration, Rectal; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Clinical Trials, Phase II as Topic; Colitis, Ulcerative; Crohn Disease; Humans; Mesalamine; Phosphatidylcholines; Pilot Projects; Practice Guidelines as Topic; Remission Induction; Treatment Outcome; Trichuris

2006
Diaphragm disease and small bowel enteropathy due to nonsteroidal anti-inflammatory drugs: a surgical perspective.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2011, Volume: 13, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Constriction, Pathologic; Diaphragm; Diclofenac; Female; Humans; Intestinal Diseases; Intestinal Mucosa; Intestinal Obstruction; Intestine, Small; Male; Mesalamine; Middle Aged; Sulfasalazine; Treatment Outcome

2011
Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
    Journal of clinical gastroenterology, 2011, Volume: 45, Issue:1

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis, Ulcerative; Cross Reactions; Drug Hypersensitivity; Female; Humans; Mesalamine

2011
Quantitative HPLC analysis of mebeverine, mesalazine, sulphasalazine and dispersible aspirin stored in a Venalink monitored dosage system with co-prescribed medicines.
    Journal of pharmaceutical and biomedical analysis, 2011, Mar-25, Volume: 54, Issue:4

    Topics: Aspirin; Capsules; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Mass Spectrometry; Medication Systems; Mesalamine; Phenethylamines; Polypharmacy; Salicylates; Sulfasalazine; Tablets; Technology, Pharmaceutical; Time Factors

2011
Avascular necrosis of the knees and ulcerative colitis.
    Revista espanola de enfermedades digestivas, 2011, Volume: 103, Issue:10

    Topics: Adrenal Cortex Hormones; Adult; Aspirin; Cholecalciferol; Colitis, Ulcerative; Cyclosporine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Knee Joint; Male; Mesalamine; Osteonecrosis; Pain; Platelet Aggregation Inhibitors; Radiography; Simvastatin; Vitamins

2011
Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas.
    Translational research : the journal of laboratory and clinical medicine, 2015, Volume: 166, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Aspirin; Cell Proliferation; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytostatic Agents; Dinoprostone; Gene Expression; Humans; Immunohistochemistry; Mesalamine; Neuroma, Acoustic; Sodium Salicylate; Translational Research, Biomedical; Tumor Cells, Cultured

2015
Mesalamine desensitization in a patient with treatment refractory ulcerative colitis and aspirin and nonsteroidal anti-inflammatory drug hypersensitivity.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2017, Volume: 118, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis, Ulcerative; Desensitization, Immunologic; Drug Hypersensitivity; Female; Humans; Mesalamine

2017
Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis.
    Inflammopharmacology, 2018, Volume: 26, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Colon; Disease Models, Animal; Intestinal Mucosa; Male; Mesalamine; Methylamines; Nitrates; Nitrites; Peroxidase; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2018
Ampholytic starch excipients for high loaded drug formulations: Mechanistic insights.
    International journal of pharmaceutics, 2018, Jan-15, Volume: 535, Issue:1-2

    Topics: Acetaminophen; Aspirin; Drug Compounding; Excipients; Mesalamine; Metformin; Starch; Tablets; Viscosity

2018
Too Soon to Discard 5-ASAs?
    The American journal of gastroenterology, 2019, Volume: 114, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biological Therapy; Colitis, Ulcerative; Humans; Mesalamine

2019
Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Scandinavian journal of gastroenterology, 2020, Volume: 55, Issue:3

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; China; Cohort Studies; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Inflammatory Bowel Diseases; Male; Mesalamine; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Registries; Risk Assessment; Young Adult

2020
Low-dose aspirin and mesalazine for patients with familial adenomatous polyposis.
    The lancet. Gastroenterology & hepatology, 2021, Volume: 6, Issue:6

    Topics: Adenomatous Polyposis Coli; Aspirin; Chemoprevention; Colectomy; Double-Blind Method; Humans; Mesalamine

2021